| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 11.422 | 87.261 | 19.634 | 38.758 |
| Total Income - EUR | - | - | - | - | - | - | 11.425 | 87.262 | 19.636 | 38.760 |
| Total Expenses - EUR | - | - | - | - | - | - | 16.893 | 80.912 | 19.288 | 25.127 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -5.469 | 6.350 | 348 | 13.632 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -5.469 | 5.675 | 152 | 11.423 |
| Employees | - | - | - | - | - | - | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Mm Genus Clinical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 589 | 397 | 1.612 |
| Current Assets | - | - | - | - | - | - | 3.397 | 20.162 | 8.184 | 17.750 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 1.569 | 1.973 | 1.181 |
| Cash | - | - | - | - | - | - | 3.397 | 18.594 | 6.211 | 16.569 |
| Shareholders Funds | - | - | - | - | - | - | -6.755 | -1.101 | -946 | 10.482 |
| Social Capital | - | - | - | - | - | - | 42 | 43 | 42 | 42 |
| Debts | - | - | - | - | - | - | 10.153 | 21.852 | 9.527 | 8.881 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mm Genus Clinical S.r.l.